United States: Accord BioPharma, Inc. Announces FDA Approval Of HERCESSI (Trastuzumab-strf) - Goodwin Procter LLP

Credit: Mondaq- Published 2 weeks ago

On April 29, 2024, Accord BioPharma, Inc. announced that the U.S. Food and Drug Administration (FDA) approved HERCESSI (trastuzumab-strf).

👓 View full article:

You are here

› Legal › United States: Accord BioPharma, Inc. Announces FDA Approval Of HERCESSI (Trastuzumab-strf) - Goodwin Procter LLP

Related videos from verified sources

Red Lobster Announces Nearly 100 Locations Will Be Shut Down 01:31

Credit: Wibbitz Top Stories - Published 5 days ago

Experts Question Claim That Yogurt Can Help Prevent Type 2 Diabetes 01:31

Credit: Wibbitz Top Stories - Published 1 week ago

FDA Testing Reveals Bird Flu Virus in 1 in 5 Milk Samples 01:31

Credit: Wibbitz Top Stories - Published 3 weeks ago

You might like